Merck & Co., Inc.
NYSE:MRKDrug Manufacturers - General
Healthcare
$137.78 -1.14%
-$1.32 today
- Market cap
- $339.66B
- Beta
- 0.22
- P/E (TTM)
- 31.6
- EPS (TTM)
- $3.61
- Dividend yield
- 2.94%
52W Low $76.66High $125.14
Volume 9.69M
Average 11.85M
News
For Merck & Co., Inc., read summarized stories built from several publishers and recent headlines with links to the original coverage.
Stories
All market newsNo stories for MRK yet. A story appears once at least three publishers cover the same event.
More headlines
Recent coverage that has not been summarized. Links open the publisher's site.
- Thomas H. Glocer to Retire From Merck Board of Directors in May 2027; Douglas M. Baker, Jr. Appointed Independent Lead Director
Business Wire
- Merck stops trials of blood cancer drug after risk assessment
Reuters
- Merck Announces Update on BELLWAVE Clinical Development Program Evaluating Nemtabrutinib
Business Wire
- Merck Announces First-Quarter 2027 Dividend
Business Wire
- Merck & Co., Inc. (NYSE:MRK) Share Price Breaks Below Fifty Day Moving Average Following Insider Selling
Defense World
- Is Merck's Stock Still a Good Buy at $150?
The Motley Fool
Continue the stock analysis
Jump to another research area for this company.